no doubt about demand. No doubt about the potential value of Ora-lyn. Nobody ever doubted the attraction of buccal delivery of insulin, particularly for the young and the old. And maybe everyone in between. Its only of real value if Ora-lyn comes to market, if the deal gets done. It never did. It was only a gleam in Dr. Anderson's eye. That's what we hope is different about the current moment: getting a vaccine to market. Selling it. Generating revenue. And generating benefit for millions of people around the globe. No, make that billions of people around the globe.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links